What is the differential diagnosis for chronic diarrhea with elevated fecal calprotectin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis for Chronic Diarrhea with Elevated Fecal Calprotectin

Elevated fecal calprotectin in chronic diarrhea primarily indicates inflammatory bowel disease (IBD), but you must also consider microscopic colitis, colorectal cancer, infectious gastroenteritis, NSAID use, and less commonly celiac disease. 1

Primary Inflammatory Conditions

Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)

  • IBD is the most likely diagnosis when fecal calprotectin exceeds 50 μg/g, with 100% sensitivity and 95% specificity in adults 2
  • Levels >250 μg/g strongly correlate with active endoscopic inflammation and suggest IBD over other causes 1
  • In Crohn's disease specifically, calprotectin levels show a topographical gradient: distal small bowel inflammation produces higher levels (190 μg/g) than proximal disease (63 μg/g), while colonic involvement yields the highest levels (542 μg/g) 3

Microscopic Colitis

  • This is a critical diagnosis to consider, as it presents with chronic watery diarrhea and moderately elevated calprotectin despite normal-appearing colonoscopy 4, 5
  • Median calprotectin in active microscopic colitis is 175 μg/g (compared to 28 μg/g in functional diarrhea) 5
  • Optimal cutoff is >100 μg/g with 67% sensitivity and 75% specificity 5
  • Active disease shows median calprotectin of 48 μg/g, which drops to 22 μg/g in remission (similar to IBS levels) 6
  • Suspect this particularly in women over 60 years old taking ≥3 medications 5

Neoplastic Disease

Colorectal Cancer

  • Calprotectin is elevated in colorectal malignancy, though the guideline notes this as a recognized cause without specific thresholds 1
  • When calprotectin is elevated in chronic diarrhea, colonoscopy is warranted to exclude malignancy 1

Infectious Causes

Infectious Gastroenteritis

  • Both bacterial and viral infections can elevate calprotectin, though bacterial causes produce higher levels 7
  • Clostridium difficile infection must be excluded using combination testing (glutamate dehydrogenase or PCR plus toxin EIA) 1
  • Consider persistent parasitic infections like giardiasis, though these may produce false-negative calprotectin results 2

Helicobacter pylori

  • Recent evidence shows H. pylori infection significantly elevates fecal calprotectin (mean 241.2 μg/g vs 88.1 μg/g in uninfected patients) 8
  • This is particularly relevant in high immigrant density populations 8

Medication-Related Causes

NSAID Use

  • Non-steroidal anti-inflammatory drugs are a well-recognized cause of elevated calprotectin without IBD 1, 2
  • This produces false-positive results in approximately 10% of cases in adults 2
  • Always obtain detailed medication history including over-the-counter NSAIDs and aspirin 2

Less Common Causes with Important Caveats

Celiac Disease

  • Celiac disease is a critical pitfall: it causes chronic diarrhea but frequently produces false-negative calprotectin results 2
  • In adults, 5 of 8 false-negative results were celiac disease patients 2
  • In children, 6 of 11 false-negative results were celiac disease 2
  • Therefore, serological screening with tissue transglutaminase or EMA must be performed regardless of calprotectin level 1

Liver Cirrhosis

  • Concomitant cirrhosis can produce false-positive elevated calprotectin (3 of 8 false-positives in one study) 2
  • Consider this in patients with known liver disease 2

Algorithmic Approach to Interpretation

For calprotectin <50 μg/g:

  • IBD is unlikely; consider functional disorders, celiac disease (must still screen), or microscopic colitis in remission 1, 6

For calprotectin 50-100 μg/g:

  • Intermediate risk zone with 8% chance of developing IBD over 12 months 1
  • Consider microscopic colitis, NSAID use, or early IBD 5

For calprotectin 100-250 μg/g:

  • High suspicion for microscopic colitis or mild IBD 5
  • Proceed to colonoscopy with random biopsies even if mucosa appears normal 5

For calprotectin >250 μg/g:

  • Strong correlation with active endoscopic inflammation, likely IBD or colorectal cancer 1
  • Urgent colonoscopy indicated 1

Critical Pitfalls to Avoid

  • Never rely on calprotectin alone to exclude celiac disease—always perform serological screening 1, 2
  • Do not dismiss normal-appearing colonoscopy—obtain random biopsies to exclude microscopic colitis when calprotectin is elevated 4, 5
  • Document all medications including NSAIDs, aspirin, and proton pump inhibitors before interpreting results 1, 2
  • Consider C. difficile testing even with elevated calprotectin, as post-infectious IBS can occur 1
  • In patients with liver disease, interpret elevated calprotectin cautiously as cirrhosis can cause false elevations 2

References

Research

Fecal calprotectin level in microscopic colitis: a systematic review and meta-analysis.

Proceedings (Baylor University. Medical Center), 2023

Research

Usefulness of fecal calprotectin as a biomarker of microscopic colitis in a cohort of patients with chronic watery diarrhoea of functional characteristics.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.